Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trialLudwig Kappos, Paul D. Crowe, Jack P. Antel et al.|Nature Medicine|2000Cited by 515
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MSG. Francis, Michel Chofflon, Richard AC Hughes et al.|DIAL (Catholic University of Leuven)|2001Cited by 472